Results 141 to 150 of about 83,548 (314)

Differentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells.

, 1989
Richard J. Rickles, Andrew L. Darrow, Sidney Strickland   +2 more
openalex   +1 more source

Release of tissue‐type plasminogen activator is induced in rats by leukotrienes C₄ and D₄, but not by prostaglandins E₁, E₂ and I₂ [PDF]

, 1988
N. Tranquille, J.J. Emeis
openalex   +1 more source

Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments

The FEBS Journal, EarlyView.
Intracellular communication controls the processing of generated signals so that every cell type can successfully respond. The extracellular matrix (ECM) is a fundamental regulator of cell communication and signaling through the strict orchestration and functions of its bioactive components.
Zoi Piperigkou, Sylvia Mangani, Nikolaos E. Koletsis, Christos Koutsakis, Nicholas S. Mastronikolis, Marco Franchi, Nikos K. Karamanos   +6 more
wiley   +1 more source

Free Flap Salvage Using Extracorporeal Tissue Plasminogen Activator Administration: A Comparative Study. [PDF]

Plast Reconstr Surg Glob Open
Johansen A, Halle M, Rittri S.
europepmc   +1 more source

A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.

, 1988
Molly Browne, J.E. Carey, C.G. Chapman, A. W. R. TYRRELL, Claire Entwisle, G. M. Lawrence, B. Reavy, Ian B. Dodd, A.F. Esmail, J.H. Robinson   +9 more
openalex   +1 more source

Human tissue‐type plasminogen activator is related to albumin and alpha‐fetoprotein [PDF]

, 1985
Michael E. Baker
openalex   +1 more source

Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis

Haemophilia, EarlyView.
ABSTRACT Background Emicizumab is a bispecific monoclonal antibody mimicking factor (F) VIII activity and an effective therapy for prophylaxis in people with haemophilia A (PWHA). The FVIII‐equivalent activity (FVIIIeq) of emicizumab remains unknown. Objectives To estimate FVIIIeq of emicizumab using global assays of haemostasis.
Daniel Kraemmer, Cihan Ay, Judit Rejtő, Georg Heinze, Peter Quehenberger, Ingrid Pabinger, Oliver Königsbrügge   +6 more
wiley   +1 more source

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

, 1989
Paolo Golino, J H Ashton, J McNatt, Pia Glas-Greenwalt, S K Yao, R A O'Brien, L. Maximilian Buja, J. T. Willerson   +7 more
openalex   +1 more source

Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to systematically review the literature on soluble biomarkers in adults with idiopathic intracranial hypertension (IIH). Background Idiopathic intracranial hypertension is a multifactorial disorder marked by elevated intracranial pressure without a clear cause.
Marina Romozzi, Fabio Zeoli, Renata Martinelli, Federico Tosto, Antonio Funcis, Giuseppe Garignano, Sabrina Chiloiro, Lucia Di Nardo, Catello Vollono, Alessandro Olivi, Paolo Calabresi, Francesco Signorelli   +11 more
wiley   +1 more source

Imaging efficacy and safety of low dose intraventricular tissue plasminogen activator in aneurysmal subarachnoid hemorrhage: case series. [PDF]

Acta Neurochir (Wien)
Liu C, Wroe WW, Zeineddine HA, Dawes B, Giordano M, McCabe A, Chen CJ, McBride DW, Gusdon AM, Choi HA, Blackburn SL.   +10 more
europepmc   +1 more source